The slip
PARKINSON RECEIPTno. 8398
24 Oct 2026, 07:06 UTCdopamine neurons, braak
predictionVRK3 in dopamine neurons tracks Braak Lewy-body stage
registeredd80254c112e610bd
discovery-0.08 p=0.832 n=9
replication-0.11 p=0.775 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.08, p 0.832)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT436936caf2c9192a615f27f6…
follows 7107c14ca9ca…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8398: VRK3 in dopamine neurons, braak
- power
- full sample -0.33 (p 0.188, n 18), 95% CI -0.69 to +0.17. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.30 (p 0.228, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.31 (p 0.204, n 18). could be the mix.
- skeptic
- leave-one-out range -0.46 to -0.23, sign flips 0; without severely affected donors -0.33 (p 0.188, n 18). fragile.
- cell type
- strongest in astrocytes: -0.73 (p 5.6e-4, n 18) vs -0.33 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for VRK3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up VRK3 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.28 p 0.328 (needs p < 2.5e-4)